CLINICAL_TRIALS trial_result · 2020-04-09

Clinical Trial Update: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ [Phase 2]

A phase 2 pilot study evaluating chemo-prevention with green tea in women with ductal carcinoma in situ was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Chicago | Conditions: Ductal Carcinoma in Situ | Phase 2 | Status: TERMINATED | Results posted: 2020-04-09